ONCOLOGIST AND HEMATOLOGISTS
Samir E. Witta, MD, PhD
Dr. Witta believes that patients with cancer should be able to receive the most advanced treatments in a very comfortable settings and with very personalized care that is respectful of their and their families’ needs and wishes, and brings either a cure or an improvement in quality of life.
With doctorates in both Genetics and Medicine, Dr. Witta offers the patients in his care a dual advantage as they fight cancer. He has collaborated with physicians, specialists locally and at the nation’s leading institutions in his 20-plus years of practice, working to develop tumor-specific treatments for better outcomes and fewer side effects.
Dr. Witta earned his PhD in Genetics from the National Institutes of Health in Bethesda, Maryland, his MD from Charles University, the oldest University in Central Europe and received his fellowship in hematology and oncology at the University of Colorado. He is board certified in Medical Oncology and Internal Medicine, and continues to publish in leading medical journals.
Voted 5280 Top Doc for three years.
David R. Trevarthen, MD
Dr. Trevarthen has been practicing Medical Oncology, and Hematology in the Denver area for over 30 years. With his many years of practice, he has extensive experience in treating all types of cancer. He does have particular interest in treating lung cancer, complex GI cancers, such as pancreatic cancer, head and neck cancer, and melanoma. He has been instrumental in developing centers of excellence for these cancers at Swedish Hospital.
Dr. Trevarthen also is passionate about cancer research, and is a principal investigator on many clinical trials for cancer. He has published scholarly papers on some of the clinical trials he has been involved with.
In his free time, when not working with cancer patients , other personal passions, include performing music, boating, and fly fishing.
Michael Pearlman, MD
Specializing in Neuro-Oncology
Dr. Pearlman is a Colorado native who returned after 10 years of post-graduate training in Houston, Texas at the Texas Medical Center. He obtained his undergraduate degree from the University of Colorado, Boulder and his medical degree from the University Of Colorado School Of Medicine. In addition to his medical degree, he earned a Ph.D. in Cancer Pharmacology from the University of Texas MD Anderson Cancer Center. He attended the University Of Texas School Of Medicine in Houston for his intern year in pediatrics and also his training in pediatric neurology.
During his pediatric neurology training he was involved in clinical research in pediatric epilepsy specifically using magnetoencephalography to localize seizure foci. Afterward his pediatric neurology residency, he completed fellowships in clinical research and neurology/oncology. He has published multiple papers in magnetoencephalography, neuro-oncology and pharmacology. He has over 14 years of post-graduate training and brings extensive clinical and research experience in translational medicine.
Ryan Weight, MD
Specializing in Derm-Oncology
Dr. Weight moved to the Denver area to establish a practice closer to his family. He believes that his patients are an extension of that family and he takes great care to foster meaningful relationships with anyone under his care. He takes pride in helping patients and their families understand the disease process so that they may make informed decisions that fit their personal goals. Dr. Weight has a reputation for the sincerity and quality of his patient care. A well-known expert in the skin cancer field, Dr. Weight practices on the cutting edge of medicine, having co-authored practice-changing clinical trials in melanoma and providing patients access to life-saving treatments through these and other clinical studies. In addition to being a part of the team at Mountain Blue Cancer Care, Dr. Weight leads the The Melanoma And Skin Cancer Institute.
"I enjoy taking care of patients diagnosed with skin cancer. My passion is in the research and treatment of skin cancers such as melanoma and I provide specialized care to patients diagnosed with these conditions, past or present.”